Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Freiberg

Orthopaedic Surgery Boston, MA Medical Doctor

NPI 1144210956 CMS profile 97453

55 Fruit Street Yaw 3918, Orthopaedic Associates, Boston, MA 02114

Open in the dashboard

General payments

$5,904,746

552 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$25,200

1 holding reported · through program year 2025

Through program year 2025, Andrew Freiberg of Boston, MA is reported in the CMS Open Payments database as having received $5,904,746 across 552 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $25,200 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $52,830 96
2024 General $38,171 71
2023 General $48,440 54
2022 General $74,572 96
2021 General $136,902 157
2020 General $46,884 31
2019 General $5,506,947 47
2019 Ownership $25,200 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Freiberg
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Andrew Freiberg were reported at $52,830. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Andrew Freiberg Orthopaedic Surgery median Middle half National median
2019 $5,506,947 $644 $140–$2,844 $163
2020 $46,884 $312 $75–$1,860 $114
2021 $136,902 $520 $117–$2,495 $132
2022 $74,572 $598 $128–$2,731 $149
2023 $48,440 $461 $128–$2,264 $160
2024 $38,171 $497 $134–$2,475 $164
2025 $52,830 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $5,852,140 509 payments
  2. Anika Therapeutics, Inc. $35,501 4 payments
  3. Stryker Corporation $16,368 31 payments
  4. Total Joint Orthopedics, Inc. $483 5 payments
  5. Smith+Nephew, Inc. $253 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $5,480,178 6 payments
  2. Consulting Fee $370,800 423 payments
  3. Current or prospective ownership or investment interest $28,843 3 payments
  4. Travel and Lodging $12,527 43 payments
  5. Acquisitions $6,658 1 payment
  6. Food and Beverage $5,612 75 payments
  7. Education $128 1 payment
Products named General payments · program years 2019–2025
  1. Persona Knees $5,440,398 29 payments
  2. Arcos $5,121,385 2 payments
  3. Persona Knees $51,595 63 payments
  4. Persona Revision $46,999 40 payments
  5. Persona Knees $27,242 23 payments
  6. Vanguard Complete Knee Solution $22,400 28 payments
  7. NexGen $16,800 19 payments
  8. MAKO $15,513 20 payments
  9. PMI/Customs $14,000 23 payments
  10. OXFORD PARTIAL KNEE $12,800 2 payments
  11. Other $232,660 334 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$141,273

Of which drugs: $226

Medicare patients

381

Average age 75

Services billed

622

244 women, 137 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 65%
Ischemic heart disease 23%
Depression 23%
Osteoporosis 21%
Cancer 16%
Chronic kidney disease 15%
Diabetes 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 13 56 $44

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

552 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record